Parkinson's disease treatment strategies appear to have similar long-term effects on disability
March 9, 2009Patients with early Parkinson disease appear to have similar overall levels of disability and quality of life six years after beginning treatment with either levodopa or a dopamine agonist, according to a report posted online today that will appear in the May print issue of Archives of Neurology. However, persistent differences are seen in some effects of these medications, including motor symptoms, fluid build-up and sleepiness.
Individuals with Parkinson disease are believed to have a depleted natural supply of the neurotransmitter dopamine. Background information in the article cites previous research indicating that patients with early Parkinson disease who begin therapy with levodopa, a medication processed into dopamine by the body, experience greater improvement in symptoms than those taking other medications. Over time, the effects of levodopa begin wearing off and patients develop more frequent motor problems, including dyskinesias (impairments in the ability to control movement). This has led some to argue in favor of initial treatment with a dopamine agonist, a drug that stimulates dopamine receptors in the brain but is not processed into dopamine by the body.
In the paper, the Parkinson Study Group CALM Cohort Investigators report on the long-term outcomes of the Comparison of the Agonist Pramipexole With Levodopa on Motor Complications of Parkinson's Disease (CALM-PD trial). Between 1996 and 1997, 301 participants with early Parkinson disease (less than seven years since diagnosis) were randomly assigned to take either levodopa or the dopamine agonist pramipexole. Clinicians involved in the study were permitted to add levodopa or other medications to the patients' therapy if disability emerged or persisted. Between June and August 2001, treatment groups were revealed to the patients and subsequent care was left to the discretion of their neurologists. A total of 222 patients (108 in the pramipexole group and 114 in the levodopa group were followed until August 2003.
After an average of six years of follow-up, most patients were taking combination therapy regardless of their initial treatment assignment, with more than 90 percent taking levodopa. Of those who started on pramipexole, more than 80 percent were still taking a dopamine agonist, with 84.1 percent of those remaining on pramipexole.
Self-reported scores on scales measuring disability, quality of life and total disease severity were similar between the group initially taking pramipexole and the group that began on levodopa. Motor complications were significantly more common in the levodopa group than in the pramipexole group (68.4 percent vs. 50 percent), but disabling dyskinesias were uncommon in both groups. Patients in the pramipexole group reported more severe somnolence (sleepiness) and were more likely to experience edema (swelling from excess fluid) than those in the levodopa group.
More information: Arch Neurol. 2009;66[5]:(doi:10.1001/archneurol.2009.32)
Source: JAMA and Archives Journals
-
Drug reduces daily 'off' time for Parkinson patients
Apr 02, 2007 |
not rated yet |
0
-
Dopamine-related drugs affect reward-seeking behavior
Apr 26, 2007 |
not rated yet |
0
-
Drug improves tremors, involuntary movements in Parkinson patients
Jan 02, 2007 |
not rated yet |
0
-
Cell-based therapy shows promise in patients with Parkinson's disease
Apr 28, 2008 |
not rated yet |
0
-
Electrode re-implantation helps some Parkinson's disease patients
May 12, 2008 |
not rated yet |
0
-
Fast photon control brings quantum photonic technologies closer
1 hour ago |
5 / 5 (2) |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (5) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
New ability to regrow blood vessels holds promise for treatment of heart disease
(Medical Xpress) -- University of Texas at Austin researchers have demonstrated a new and more effective method for regrowing blood vessels in the heart and limbs a research advancement that could have ...
57 minutes ago |
5 / 5 (3) |
0
|
Motivation to exercise affects behavior
(Medical Xpress) -- For many people, the motivation to exercise fluctuates from week to week, and these fluctuations predict whether they will be physically active, according to researchers at Penn State. In an effort to ...
47 minutes ago |
not rated yet |
0
|
'It's not nutritious until it's eaten'
As part of her "Let's Move! Initiative," First Lady Michelle Obama unveiled a new web resource highlighting new changes in the Chefs Move to Schools, during a CMST gathering in Dallas, TX today. CMTS advocates ...
34 minutes ago |
not rated yet |
0
New tumor suppressor gene identified
A recent study published in Clinical Cancer Research suggests that the protein hVps37A suppresses tumor growth in ovarian cancer. The work, which was funded by the Austrian Science Fund FWF, shows, for th ...
1 hour ago |
4.7 / 5 (3) |
0
Social psychologist: Lust makes you smarter and evidence that seven deadly sins are good for you
(Medical Xpress) -- Good news for lovers on Valentine’s Day - the seven deadly sins, including Lust, are good for you. University of Melbourne social psychologist Dr Simon Laham uses modern research to make a compelling ...
Medicine & Health / Psychology & Psychiatry
3 hours ago |
4.5 / 5 (2) |
0
Fast photon control brings quantum photonic technologies closer
(PhysOrg.com) -- Using photons instead of electrons to transmit information could lead to faster and more secure ways to communicate, among other advantages. Now a team of physicists has taken another step toward realizing ...
Planck mission steps closer to the cosmic blueprint
(PhysOrg.com) -- ESA's Planck mission has revealed that our Galaxy contains previously undiscovered islands of cold gas and a mysterious haze of microwaves. These results give scientists new treasure to mine ...
A lost world? How zooarchaeology can inform biodiversity conservation
A new study of tropical forests will provide a 50,000-year perspective on how animal biodiversity has changed, explored through an archaeological investigation of animal bones.
Myths and shame keep many from seeking bankruptcy protection
(PhysOrg.com) -- Two interesting facts that may counter modern ideas about bankruptcy: The overwhelming majority of U.S. filings belong to individuals rather than corporations or entities, and most of these ...
Big Society could threaten biodiversity conservation
A study of the Moray Firth Seal Management Plan (MFSMP), in north-east Scotland, identified four key conditions for long-term success, three of which pointed to the importance of direct government involvement.
Independent group inspects Apple supplier
(AP) -- An independent group, the Fair Labor Association, has started auditing Apple Inc.'s Chinese supplier Foxconn after a request by Apple.